close
This ad will auto close in 10 seconds

HC blocks launch of Reliance breast cancer drug till Nov 17

Noting "serious issues" in a plea opposing Reliance Life Sciences' move to launch a breast and gastric cancer drug allegedly similar to that made by Swiss pharma major Roche's subsidiary Genentech Inc., Delhi High Court has directed the Indian firm not to release the product in the market till the next date of hearing.

Roche launches new breast cancer drugs in India

Swiss drug major Roche has launched in India two new medicines for treating breast cancer claiming increased survival benefit and improved quality of life for patients.

New way to treat aggressive breast cancer reported

Researchers have reported a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer.

Biocon releases drug to treat breast cancer

India`s leading biotechnology firm Biocon Ltd. has released a new drug to treat metastatic breast cancer it developed jointly with US-based pharma major Mylan.

Jab that can revolutionise breast cancer cure gets green light from NHS

An injection that could revolutionise breast cancer treatment has been granted a licence for use in Britain.

Roche not to pursue patent for breast cancer drug in India

Swiss pharma major Roche Holding AG Friday said it won't pursue the secondary patent for its breast cancer drug 'Herceptin' in India.

Govt says Roche didn't follow norms for cancer drug patent

The government today said it had "treated as withdrawn" patent applications by Swiss pharma major Roche Holding for offshoot medicines of its breast cancer drug 'Herceptin' because the company did not comply with local norms.

India partly revokes Roche cancer drug patent

India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.

Super vaccine for lethal cancers by 2020!

Scientists have developed a new vaccine that could fight seven in ten lethal cancers and is thought to be even more effective than the ‘wonder drug’ Herceptin.